Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Anti-VEGF oligonucleotides inhibit retinal neovascularization in preclinical model

May 17, 1996

SnET2 enters phase I/II for AMD indication

May 17, 1996

Pharmos, Bausch & Lomb expand Lotemax agreement

May 17, 1996

Dorzolamide approved for marketing in Canada

May 17, 1996

AI-300 effective in preliminary clinical study

May 10, 1996

Verteporfin effective in treating severe age-related macular degeneration in early trials

May 3, 1996

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

ISV-205 research results presented at vision conference

April 26, 1996

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...